Gene Query: RABGEF1

Dataset Description Geneva Score
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 45.21
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 45.21
Identification of IL-27 as potent regulator of inflammatory osteolysis associated with vitamin E-blended ultra-high molecular weight polyethylene debris of orthopedic implants 30.38
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 30.11
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 25.29
Transcriptomic profiling of human CD34+ derived mast cells [RNA-Seq] 23.05
Landscape of human mast cell chromatin: a rich resource for identification of novel mediators and genetic drivers of allergic and inflammatory diseases 23.05
Effect of Hotair overexpression in human breast cancer cell lines 18.52
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 17.89
Transcriptomic profiling of human peripheral blood-derived mast cells 17.89
Mycobacterium bovis Bacillus Calmette-Guerin (BCG) reprograms melanoma microenvironment to promote antitumor T cell responses 17.54
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 17.41
Global transcriptional changes in U87MG glioblastoma cells upon shRNA-mediated TRIM52 knockdown 17.01
KLF4 as a rheostat of osteolysis and osteogenesis in prostate tumors in the bone 15.03
RNA-Sequencing of HepG2 cells treated with TGFBeta 14.88
R430: A potent inbibitor of DNA and RNA viruses 14.27
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 13.35
Expression analysis of Mebendazole treated THP-1 cells in three paired samples 13.2
SETDB1 compacts the inactive X chromosome in part through silencing an enhancer in the IL1RAPL1 gene 12.59
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 12.22
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers (RNA-Seq) 12.22
Transcription factor p63 bookmarks genomic loci in epithelial cells and regulates a subset of target genes during epidermal differentiation through dynamic enhancers 12.22
RNA-sequencing of human tendon after injury 12.08
Primary human trophoblast from term placenta 11.34
MeRIP-seq for heat shock in B-cell lymphoma cells 11.23
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 10.97
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 10.97
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 10.71
Tracking of dCas9-methyltransferase footprints 10.49
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 10.41
Analysis and expansion of the eosinophilic esophagitis transcriptome by RNA sequencing 9.81
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 9.56
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 9.46
Control of prostate tumour growth by the long non-coding RNA GHSROS 9.33
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.91
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.86
Intron retention induced by microsatellite expansions as a disease biomarker. 8.78
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 8.72
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 8.72
RNA-seq analysis of human cardiosphere cells with different tubule supportive potential 8.6
The evolution of N6-methyladenosine in primates 8.31
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 8.21
Mapping interactions for the TNIP2 hub protein 8.13
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 8.09
Gene expression changes after LOC550643 silencing 7.87
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 7.81
Region-specific Innate Antiviral Responses of the Human Epididymis 7.74
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.47
The effect of Foxc1 deficiency on undifferentiated and differentiated human primary keratinocytes 7.16
Survival of pancreatic cancer cells lacking KRAS function 7.15
Global transcriptional profiling changes upon knockout of USP22 in human Non-small cell lung cancer cells 7.13
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 7.03
Gene expression in PANC1 cells treated with Rakicidin 7.01
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES 6.94
SIGNAL INTEGRATION AND TRANSCRIPTIONAL REGULATION OF THE INFLAMMATORY RESPONSE MEDIATED BY THE GM-/M-CSF SIGNALING AXIS IN HUMAN MONOCYTES [RNA-seq] 6.94
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 6.81
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 6.77
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 6.7
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 6.69
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 6.66
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 6.63
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.6
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.6
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 6.59
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 6.59
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 6.59
Investigation about fibroblasts of different origins in culture 6.57
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 6.47
JunB control of keratinocyte-mediated inflammation [RNA-seq] 6.47
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 6.4
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 6.3
BAF controls genome accessibility 6.26
Seletive inhibition of CDK9 in DLBCL cell lines 6.25
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 6.23
Transcriptomic and gene ontology profiling of the human corneal cell types 6.22
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 6.18
CD95L derived si- and shRNAs kill cancer cells through an RNAi mechanism by targeting survival genes [shL3.shR6.RNAseq.lg] 6.1
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 6.07
Integrating single-cell transcriptomic data across different conditions, technologies, and species 6.05
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 [RNA-seq] 6.05
ARID2 promotes clear cell renal cell carcinoma in the absence of functional PBRM1 6.05
Noncoding regions are the main source of targetable tumor-specific antigens 6.04
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 6.03
Transcriptome analysis in Neobractatin treated cells 6.02
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 5.97
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 5.97
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 5.93
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 5.85
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 5.85
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 5.82
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 5.74
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 5.71
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 5.71
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 5.71
RNA-Seq in neutrophils from Antiphospholipid Syndrome 5.7
Reprogramming by de-bookmarking somatic transcriptional program via targeting the BET bromodomains 5.7
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 5.56
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 5.56
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 5.55
Characterization of parental and rociletinib-resistant derived H1975 cell lines 5.54
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 5.5
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.5
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 5.46
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 5.43
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 5.41
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 5.35
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 5.25
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 5.25
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.2
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 5.16
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 5.13
LNCaP treated with iBET 5.11
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 5.1
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.09
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.07
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 5.07
DART-seq: an antibody-free method for global m6A detection 5.06
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 5.06
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 5.06
Episomal HBV persistence within transcribed host nuclear chromatin compartments involves HBx 5.05
The role of CFTR in islet function 5.01
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors [RNA-Seq] 5.0
Coding mutations and loss-of-imprinting in human pluripotent cells derived by nuclear transfer and defined factors 5.0
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 4.99
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 4.98
SMN deficiency in spinal muscular atrophy causes widespread intron retention and DNA damage 4.97
mTOR hyperactivation in Down Syndrome mediates deficits in autophagy induction, autophagosome formation, and mitophagy 4.95
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.91
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 4.9
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 4.89
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 4.89
PTHrP overexpression in MCF7 cells 4.88
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 4.84
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 4.83
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 4.77
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 4.76
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 4.73
single cell RNA-seq from GM12878 (ENCSR673UIY) 4.7
SLIGRL-induced gene expression changes in NHEK cells 4.67
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 4.59
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 4.59
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.58
MARCKS and lnc-MARCKS act as inflammation regulators 4.57
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 4.56
Gene expression profile in FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA using RNA-seq. 4.52
FTSEC cells (FT190 and FT194 cell lines) transduced with shRNA to knockdown RNF20 or with control shRNA 4.52
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 4.52
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 4.51
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes 4.51
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 4.48
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 4.45
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 4.45
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 4.43
TSLP acts on neutrophils to drive complement-mediated killing of methicillin-resistant Staphylococcus aureus 4.42
Ebola virus (EBOV) infection of ARPE-19 cells 4.41
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.39
Gene expression analysis of dengue-infected cells 4.39
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 4.38
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 4.38
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 4.37
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 4.36
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 4.36
Differentially expressed (DE) genes analysis in synovial fluid mesenchymal stem cells (SF-MSCs), SF-MSC derived iPSCs and iPSC derived MSCs (iPSC-MSCs) 4.34
Molecular pathogenesis of human prostate basal cell hyperplasia reveals a keratinocyte metaplasia 4.32
Genes significantly down or Up-regulated upon RNF219 knockdown 4.32
Characterization of human ILC2 subsets 4.32
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 4.28
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 4.28
Effect of Influenza virus infection on lncRNA expression in A549 cells 4.26
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 4.24
Adipocyte-derived lipids mediate melanoma progression via FATP proteins 4.23
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 4.22
Genetic-to-epigenetic Therapy for Pancreatic Cancer 4.22
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 4.22
Effect of BB608 on Gene Expression in HNSCC Cell Line 4.21
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 4.2
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 4.2
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 4.18
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 4.18
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.17
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 4.14
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 4.14
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation 4.14
Assembly of methylated LSD1 and CHD1 drives AR-dependent transcription and translocation [RNA-Seq] 4.14
Transcriptomic analyssis following EHMT1/2 inhibition 4.14
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.13
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.13
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 4.09
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 4.09
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 4.09
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 4.09
ZIKV infection of monocytes activates inflammasome pathways 4.08
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 4.08
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 4.08
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 4.07
Transcriptomic profiling of normal human cardiac fibroblast treated with halofuginone 4.07
RNA-seq and m6A-seq of AML cells with FTO knockdown or inhibition 4.05
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 4.04
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 4.04
Genome wide miR-191 target profile determined by RIP and gene expression profiling 4.02
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 4.02
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 4.01
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 4.01
Transcriptome analysis of kidney organoids 4.0
oxLDL exposed trained monocytes 3.99
Transcriptomes of oxLDL exposed trained monocytes 3.99
High level DNA repair gene expression in human ES cells 3.97
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 3.96
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 3.94
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 3.92
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 3.89
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 3.86
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 3.86
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.85
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 3.85
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 3.83
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 3.83
Investigation about Monocytes in metastatic breast cancer patients under chemotherapy +/- Avastin 3.78
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 3.78
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.77
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.77
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 3.71
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 3.69
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 3.69
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 3.68
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 3.68
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 3.68
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 3.67
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells 3.66
Identification of renal resident macrophages across species 3.65
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 3.63
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 3.63
RNA-sequencing in immortalized human mammary epithelial cells 3.61
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 3.61
nELAVL HITS-CLIP in Alzheimer's Disease patients 3.6
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family (RNA-seq) 3.58
Regulation of DNA methylation landscape in human somatic cell reprogramming by miR-29 family 3.58
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 3.57
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 3.57
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.52
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 3.51
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 3.51
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 3.51
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 3.51
Comprehensive comparative analysis of 5’ end RNA sequencing methods 3.5
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 3.46
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 3.44
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 3.43
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.38
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 3.3
p63 controls the enhancer landscape during keratinocyte differentiation 3.28
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 3.23
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 3.22
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 3.21
The gene expression profiles of gallbladder cancer 3.21
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 3.19
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.17
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.15
Splicing and epigenetic factors jointly regulate epidermal differentiation 3.15
Gene expression in GBM with Cav3.2 inhibition 3.14
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 3.11
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 3.1
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 3.08
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 3.07
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 3.07
CD74 role in transcription regulation 3.05
CD74 role in transcription regulation [RNA-seq] 3.05
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 2.99
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.98
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.98
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 2.95
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 2.95
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.93
Human primary macrophages derived in vitro from circulating monocytes comprise adherent and non-adherent subsets with differential expression of Siglec-1 and CD4 and permissiveness to HIV-1 infection 2.93
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 2.93
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 2.89
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 2.89
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 2.88
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans [human scRNA-seq] 2.88
Single cell analysis of smooth muscle cell phenotypic modulation in vivo during disease in mice and humans 2.88
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 2.88
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 2.88
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 2.85
Transcriptional responses of melanoma cells to BRAF inhibition 2.85
UV_24h_GRO-Seq 2.84
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 2.82
RNA-seq of cancer cell lines treated with T-025 2.81
mRNA expression in human DAOY cells 2.79
Dissecting cell composition and cell-cell interaction network of normal human heart tissue by single-cell sequencing 2.79
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 2.79
Transcriptome profiling of 5 human adenocarcinoma cell lines 2.78
SILAC identifies LAD1 as an oncogenic filamin binder regulating actin dynamics in response to EGF and marking aggressive breast tumors 2.77
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 2.77
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.77
Loss of 9p21 regulatory hub promotes kidney cancer progression by upregulating HOXB13 2.75
Differential mRNA expression upon 9p21 deletion in HEK TE single-cell derived clones 2.75
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.74
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 2.74
Epigenetic reprogramming of melanoma cells by vitamin C treatment 2.71
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 2.7
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 2.69
Dissecting the single-cell transcriptome network underlying gastric premalignant lesions and early gastric cancer [10x genomics] 2.68
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 2.66
Next generation sequencing of human hepatic stellate cell line, LX-2 treated with recombinant human TGF-β1, with DMSO or ML290 (5 µM) for 72h. 2.64
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 2.64
Recovery and analysis of nascent RNA 2.64
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 2.63
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 2.61
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 2.61
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 2.55
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 2.53
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 2.53
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 2.53
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.53
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 2.53
Tissue-resident memory T cells mediate immune homeostasis in the human pancreas through the PD-1/PD-L1 pathway 2.49
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 2.4
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 2.39
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.36
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 2.33
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 2.33
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.33
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 2.32
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 2.32
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 2.29
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 2.27
Splicing and gene expression changes in human mammary epithelial MCF-10A cells expressing SR or SR-like proteins 2.2
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 2.2
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 2.2
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 2.17
Azithromycin induces epidermal differentiation and multivesicular bodies in airway epithelia 2.17
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 2.17
Cell responses to dysregulated VZV-induced cell-cell fusion 2.17
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 2.16
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 2.15
Transcriptional response to the HSP70 inhibitor MAL3-101 in parental rhabdomyosarcoma cells and isogenic acquired-resistance lines. 2.12
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.08
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.08
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 2.07
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 2.06
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 2.05
K562 polyA RNA-Seq 2.04
CT Irradiation Induced Changes of Gene Expression within Peripheral Blood Cells 2.03
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.03
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 2.03
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 2.02
Effect of nuclear IL-33 on gene expression 1.98
Transcriptional profiles of human blood dendritic cell (DC) subsets at steady state 1.96
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 1.93
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 1.91
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 1.9
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.87
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.87
Compensatory Csf2-driven macrophage activation blunts long-term efficacy of therapeutic Csf1r inhibition in breast-to-brain metastasis 1.87
Tpl-2 and MEK small molecule inhibitors 1.83
Tpl-2 small molecule project 1.83
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 1.82
Epigenomes and Transcriptomes of human monocytes from Hyper IgD Syndrome (HIDS) patients 1.8
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 1.8
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 1.79
RNA-seq of IL-4 stimulated human keratinocytes 1.79
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.79
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.79
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 1.78
An integrative analysis of non-coding regulatory DNA variations associated with autism 1.78
Regulation of protein translation during mitosis 1.77
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.75
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 1.75
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 1.74
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 1.74
Transcriptome of diurnal human blood neutrophils 1.73
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 1.73
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 1.72
Transcriptome profiling of influenza virus-infected human bronchial epithelial cells 1.71
Ribosome profiling upon inhibition of eIF4A 1.6
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.57
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 1.51
shRNA knockdown of YAP1 in HCC364 cells, various drug conditions 1.51
TOP2B disturbed the quality of human oocytes with advanced maternal age 1.5
Role of cervicovaginal microbiota in genital inflammation 1.49
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 1.47
RNAseq of quiescent (Q) and stress induced premature senescent (SIPS) fibroblasts treated with plant extract (1201) from Solidago vigaurea subspecies alpestris 1.47
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.43
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 1.43
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 1.43
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 1.39
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.35
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.35
Identification of a LIF-responsive replication-competent human β cell 1.31
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.3
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.28
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 1.28
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 1.28
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 1.27
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 1.27
Functional significance of the HIV-1 Tat signature amino acid residues 1.26
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 1.24
Reprogrammed myeloid cell transcriptomes in NSCLC 1.24
RNA-seq of primary patient AML samples 1.21
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 1.21
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 1.19
Transcriptional differences between skin from patients with atopic dermatitis and control skin obtained from the healthy margins of Mohs surgery patients 1.19
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 1.15
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 1.12
HBEC-shp53-PCHD7 1.12
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 1.1
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.1
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.1
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.1
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 1.09
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.09
Gene expression profile in breast cancer cells 1.09
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 1.04
Downregulation of LATS kinases alters p53 to promote cell migration 0.99
Loss of CREBBP results in H3K27Ac loss at enhancers and gene expression repression in lymphoma cells 0.99
Loss of CREBBP results in gene expression repression in lymphoma cells 0.99
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 0.98
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 0.98
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.97
Random mono-allelic expression in MECP2-mutated cells 0.97
Effects of transcription on genome - nuclear lamina interactions 0.96
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.96
Single-cell survey of human lymphatics unveils marked endothelial cell heterogeneity and mechanisms of homing for neutrophils 0.96
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.94
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.92
CD90 Identifies Adventitial Mesenchymal Progenitor Cells in Adult Humans 0.9
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition [RNA-Seq] 0.88
Cooptation of tandem DNA repeats for the control of epithelial-to-mesenchymal transition. 0.88
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.88
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 0.87
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.87
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.85
Host transcriptome analysis of Aspergillus fumigatus infection in Airway Epithelial Cells 0.81
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 0.8
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 0.79
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.77
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.77
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 0.76
Leucegene: AML sequencing (part 6) 0.76
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 0.74
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.73
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 0.73
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 0.73
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.72
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.71
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 0.66
Small-molecule targeting of brachyury transcription factor addiction in chordoma 0.65
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 0.63
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.63
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.63
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 0.63
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 0.61
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.6
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.59
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 0.59
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 0.57
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.55
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.53
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.51
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.51
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer [RNA-Seq] 0.51
A Suv39H1-low chromatin state drives migratory cell populations in cervical cancer 0.51
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 0.49
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.46
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.44
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.44
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.44
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.44
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.44
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.43
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.42
Effect of low-dose sorafenib and alkylating agents in inflammation and angiogenesis in breast cancer 0.41
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.41
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.41
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.4
A code of mono-phosphorylation modulates the function of RB. 0.39
A549 cell transcriptome responses to infection with H7N9 influenza virus 0.38
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 0.35
4sUDRB-seq: measuring transcription elongation and initiation genomewide 0.32
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.32
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 0.3
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.27
Next Generation Sequencing of Lung Primary Fibroblast Responding to Eosinophil-Degranulation Products 0.27
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.27
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.27
Human Treg IFNg/IL-10 subpopulations 0.25
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 0.23
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.19
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.18
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.18
RNA-seq data 0.12
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.11
A toxicogenomics approach to screen chlorinated flame retardants tris(2-chloroethyl) phosphate and tris(2-chloroisopropyl) phosphate for potential health effects 0.1
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.09
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.06
Neurotrophic Tyrosine Kinase Receptor 1 is Epigenetically Regulated by IL-13 and Contributes to Allergic Inflammation 0.06
NHLRC1 re-expression in cancer cells 0.03
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.03
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.02
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation